nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—CYP1A2—Progesterone—uterine cancer	0.0859	0.396	CbGbCtD
Duloxetine—CYP2D6—Progesterone—uterine cancer	0.0708	0.326	CbGbCtD
Duloxetine—CYP1A2—Etoposide—uterine cancer	0.0385	0.177	CbGbCtD
Duloxetine—CYP2D6—Doxorubicin—uterine cancer	0.0216	0.0997	CbGbCtD
Duloxetine—NPY1R—myometrium—uterine cancer	0.00807	0.137	CbGeAlD
Duloxetine—NPY1R—uterine cervix—uterine cancer	0.00628	0.106	CbGeAlD
Duloxetine—NPY1R—renal system—uterine cancer	0.00587	0.0996	CbGeAlD
Duloxetine—NPY1R—mammalian vulva—uterine cancer	0.00549	0.0931	CbGeAlD
Duloxetine—NPY1R—female reproductive system—uterine cancer	0.0047	0.0798	CbGeAlD
Duloxetine—NPY1R—vagina—uterine cancer	0.00425	0.0721	CbGeAlD
Duloxetine—HTR2A—artery—uterine cancer	0.00341	0.0578	CbGeAlD
Duloxetine—NPY1R—lymph node—uterine cancer	0.00275	0.0467	CbGeAlD
Duloxetine—SLC6A2—decidua—uterine cancer	0.00203	0.0344	CbGeAlD
Duloxetine—HTR2C—female reproductive system—uterine cancer	0.00191	0.0324	CbGeAlD
Duloxetine—SLC6A4—female reproductive system—uterine cancer	0.00181	0.0308	CbGeAlD
Duloxetine—SLC6A2—female reproductive system—uterine cancer	0.0016	0.0271	CbGeAlD
Duloxetine—CYP1A2—renal system—uterine cancer	0.00153	0.026	CbGeAlD
Duloxetine—HTR2A—epithelium—uterine cancer	0.00129	0.0219	CbGeAlD
Duloxetine—HTR2A—smooth muscle tissue—uterine cancer	0.00124	0.0211	CbGeAlD
Duloxetine—HTR2A—renal system—uterine cancer	0.0012	0.0203	CbGeAlD
Duloxetine—CYP2D6—renal system—uterine cancer	0.00109	0.0185	CbGeAlD
Duloxetine—HTR2A—female reproductive system—uterine cancer	0.00096	0.0163	CbGeAlD
Duloxetine—SLC6A2—lymph node—uterine cancer	0.000934	0.0158	CbGeAlD
Duloxetine—CYP2D6—female reproductive system—uterine cancer	0.000874	0.0148	CbGeAlD
Duloxetine—HTR2A—vagina—uterine cancer	0.000868	0.0147	CbGeAlD
Duloxetine—CYP2D6—female gonad—uterine cancer	0.000795	0.0135	CbGeAlD
Duloxetine—Thrombocytopenia—Etoposide—uterine cancer	0.000498	0.000687	CcSEcCtD
Duloxetine—Tachycardia—Etoposide—uterine cancer	0.000496	0.000685	CcSEcCtD
Duloxetine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000495	0.000684	CcSEcCtD
Duloxetine—Skin disorder—Etoposide—uterine cancer	0.000494	0.000682	CcSEcCtD
Duloxetine—Hyperhidrosis—Etoposide—uterine cancer	0.000491	0.000679	CcSEcCtD
Duloxetine—Pancreatitis—Epirubicin—uterine cancer	0.000491	0.000679	CcSEcCtD
Duloxetine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.00049	0.000677	CcSEcCtD
Duloxetine—Abdominal pain upper—Doxorubicin—uterine cancer	0.00049	0.000677	CcSEcCtD
Duloxetine—Breast disorder—Doxorubicin—uterine cancer	0.000485	0.00067	CcSEcCtD
Duloxetine—Anorexia—Etoposide—uterine cancer	0.000485	0.000669	CcSEcCtD
Duloxetine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000483	0.000667	CcSEcCtD
Duloxetine—Diarrhoea—Dactinomycin—uterine cancer	0.000481	0.000664	CcSEcCtD
Duloxetine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00048	0.000663	CcSEcCtD
Duloxetine—Gastritis—Doxorubicin—uterine cancer	0.000475	0.000656	CcSEcCtD
Duloxetine—Muscular weakness—Doxorubicin—uterine cancer	0.000473	0.000653	CcSEcCtD
Duloxetine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000473	0.000653	CcSEcCtD
Duloxetine—Dysuria—Epirubicin—uterine cancer	0.000469	0.000647	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000466	0.000643	CcSEcCtD
Duloxetine—Dysphagia—Doxorubicin—uterine cancer	0.000464	0.00064	CcSEcCtD
Duloxetine—Influenza—Doxorubicin—uterine cancer	0.000464	0.00064	CcSEcCtD
Duloxetine—Pollakiuria—Epirubicin—uterine cancer	0.000463	0.000639	CcSEcCtD
Duloxetine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000457	0.000632	CcSEcCtD
Duloxetine—Paraesthesia—Etoposide—uterine cancer	0.000457	0.00063	CcSEcCtD
Duloxetine—Weight increased—Epirubicin—uterine cancer	0.000456	0.00063	CcSEcCtD
Duloxetine—Pancreatitis—Doxorubicin—uterine cancer	0.000455	0.000628	CcSEcCtD
Duloxetine—Weight decreased—Epirubicin—uterine cancer	0.000453	0.000626	CcSEcCtD
Duloxetine—Hyperglycaemia—Epirubicin—uterine cancer	0.000452	0.000624	CcSEcCtD
Duloxetine—Somnolence—Etoposide—uterine cancer	0.000452	0.000624	CcSEcCtD
Duloxetine—Infestation NOS—Epirubicin—uterine cancer	0.000447	0.000617	CcSEcCtD
Duloxetine—Infestation—Epirubicin—uterine cancer	0.000447	0.000617	CcSEcCtD
Duloxetine—Vomiting—Dactinomycin—uterine cancer	0.000447	0.000617	CcSEcCtD
Duloxetine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000443	0.000612	CcSEcCtD
Duloxetine—Rash—Dactinomycin—uterine cancer	0.000443	0.000612	CcSEcCtD
Duloxetine—Decreased appetite—Etoposide—uterine cancer	0.000442	0.00061	CcSEcCtD
Duloxetine—Renal failure—Epirubicin—uterine cancer	0.000439	0.000607	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000439	0.000606	CcSEcCtD
Duloxetine—Fatigue—Etoposide—uterine cancer	0.000438	0.000605	CcSEcCtD
Duloxetine—Jaundice—Epirubicin—uterine cancer	0.000436	0.000602	CcSEcCtD
Duloxetine—Stomatitis—Epirubicin—uterine cancer	0.000436	0.000602	CcSEcCtD
Duloxetine—Constipation—Etoposide—uterine cancer	0.000435	0.0006	CcSEcCtD
Duloxetine—Pain—Etoposide—uterine cancer	0.000435	0.0006	CcSEcCtD
Duloxetine—Conjunctivitis—Epirubicin—uterine cancer	0.000434	0.0006	CcSEcCtD
Duloxetine—Urinary tract infection—Epirubicin—uterine cancer	0.000434	0.0006	CcSEcCtD
Duloxetine—Dysuria—Doxorubicin—uterine cancer	0.000434	0.000599	CcSEcCtD
Duloxetine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000431	0.000595	CcSEcCtD
Duloxetine—Pollakiuria—Doxorubicin—uterine cancer	0.000428	0.000592	CcSEcCtD
Duloxetine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000423	0.000585	CcSEcCtD
Duloxetine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000423	0.000584	CcSEcCtD
Duloxetine—Weight increased—Doxorubicin—uterine cancer	0.000422	0.000583	CcSEcCtD
Duloxetine—Epistaxis—Epirubicin—uterine cancer	0.000421	0.000582	CcSEcCtD
Duloxetine—Weight decreased—Doxorubicin—uterine cancer	0.00042	0.000579	CcSEcCtD
Duloxetine—Feeling abnormal—Etoposide—uterine cancer	0.000419	0.000579	CcSEcCtD
Duloxetine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000418	0.000578	CcSEcCtD
Duloxetine—Nausea—Dactinomycin—uterine cancer	0.000417	0.000576	CcSEcCtD
Duloxetine—Gastrointestinal pain—Etoposide—uterine cancer	0.000416	0.000574	CcSEcCtD
Duloxetine—Infestation NOS—Doxorubicin—uterine cancer	0.000413	0.000571	CcSEcCtD
Duloxetine—Infestation—Doxorubicin—uterine cancer	0.000413	0.000571	CcSEcCtD
Duloxetine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00041	0.000566	CcSEcCtD
Duloxetine—Renal failure—Doxorubicin—uterine cancer	0.000406	0.000561	CcSEcCtD
Duloxetine—Urticaria—Etoposide—uterine cancer	0.000404	0.000558	CcSEcCtD
Duloxetine—Haemoglobin—Epirubicin—uterine cancer	0.000403	0.000557	CcSEcCtD
Duloxetine—Jaundice—Doxorubicin—uterine cancer	0.000403	0.000557	CcSEcCtD
Duloxetine—Stomatitis—Doxorubicin—uterine cancer	0.000403	0.000557	CcSEcCtD
Duloxetine—Abdominal pain—Etoposide—uterine cancer	0.000402	0.000555	CcSEcCtD
Duloxetine—Body temperature increased—Etoposide—uterine cancer	0.000402	0.000555	CcSEcCtD
Duloxetine—Conjunctivitis—Doxorubicin—uterine cancer	0.000402	0.000555	CcSEcCtD
Duloxetine—Urinary tract infection—Doxorubicin—uterine cancer	0.000402	0.000555	CcSEcCtD
Duloxetine—Haemorrhage—Epirubicin—uterine cancer	0.000401	0.000554	CcSEcCtD
Duloxetine—Hepatitis—Epirubicin—uterine cancer	0.000401	0.000554	CcSEcCtD
Duloxetine—Hypoaesthesia—Epirubicin—uterine cancer	0.000399	0.000551	CcSEcCtD
Duloxetine—Pharyngitis—Epirubicin—uterine cancer	0.000398	0.00055	CcSEcCtD
Duloxetine—Urinary tract disorder—Epirubicin—uterine cancer	0.000396	0.000547	CcSEcCtD
Duloxetine—Oedema peripheral—Epirubicin—uterine cancer	0.000395	0.000546	CcSEcCtD
Duloxetine—Connective tissue disorder—Epirubicin—uterine cancer	0.000394	0.000544	CcSEcCtD
Duloxetine—Urethral disorder—Epirubicin—uterine cancer	0.000393	0.000543	CcSEcCtD
Duloxetine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000391	0.00054	CcSEcCtD
Duloxetine—Epistaxis—Doxorubicin—uterine cancer	0.00039	0.000539	CcSEcCtD
Duloxetine—Visual impairment—Epirubicin—uterine cancer	0.000387	0.000534	CcSEcCtD
Duloxetine—Erythema multiforme—Epirubicin—uterine cancer	0.000379	0.000524	CcSEcCtD
Duloxetine—Eye disorder—Epirubicin—uterine cancer	0.000375	0.000518	CcSEcCtD
Duloxetine—Hypersensitivity—Etoposide—uterine cancer	0.000375	0.000517	CcSEcCtD
Duloxetine—Tinnitus—Epirubicin—uterine cancer	0.000374	0.000516	CcSEcCtD
Duloxetine—Haemoglobin—Doxorubicin—uterine cancer	0.000373	0.000515	CcSEcCtD
Duloxetine—Flushing—Epirubicin—uterine cancer	0.000372	0.000514	CcSEcCtD
Duloxetine—Cardiac disorder—Epirubicin—uterine cancer	0.000372	0.000514	CcSEcCtD
Duloxetine—Hepatitis—Doxorubicin—uterine cancer	0.000371	0.000513	CcSEcCtD
Duloxetine—Haemorrhage—Doxorubicin—uterine cancer	0.000371	0.000513	CcSEcCtD
Duloxetine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000369	0.00051	CcSEcCtD
Duloxetine—Pharyngitis—Doxorubicin—uterine cancer	0.000368	0.000509	CcSEcCtD
Duloxetine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000367	0.000506	CcSEcCtD
Duloxetine—Oedema peripheral—Doxorubicin—uterine cancer	0.000366	0.000505	CcSEcCtD
Duloxetine—Asthenia—Etoposide—uterine cancer	0.000365	0.000504	CcSEcCtD
Duloxetine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000365	0.000504	CcSEcCtD
Duloxetine—Angiopathy—Epirubicin—uterine cancer	0.000364	0.000503	CcSEcCtD
Duloxetine—Urethral disorder—Doxorubicin—uterine cancer	0.000364	0.000502	CcSEcCtD
Duloxetine—Immune system disorder—Epirubicin—uterine cancer	0.000362	0.0005	CcSEcCtD
Duloxetine—Mediastinal disorder—Epirubicin—uterine cancer	0.000362	0.000499	CcSEcCtD
Duloxetine—Chills—Epirubicin—uterine cancer	0.00036	0.000497	CcSEcCtD
Duloxetine—Pruritus—Etoposide—uterine cancer	0.00036	0.000497	CcSEcCtD
Duloxetine—Arrhythmia—Epirubicin—uterine cancer	0.000358	0.000495	CcSEcCtD
Duloxetine—Visual impairment—Doxorubicin—uterine cancer	0.000358	0.000494	CcSEcCtD
Duloxetine—Alopecia—Epirubicin—uterine cancer	0.000354	0.00049	CcSEcCtD
Duloxetine—Mental disorder—Epirubicin—uterine cancer	0.000351	0.000485	CcSEcCtD
Duloxetine—Erythema multiforme—Doxorubicin—uterine cancer	0.000351	0.000485	CcSEcCtD
Duloxetine—Malnutrition—Epirubicin—uterine cancer	0.000349	0.000482	CcSEcCtD
Duloxetine—Erythema—Epirubicin—uterine cancer	0.000349	0.000482	CcSEcCtD
Duloxetine—Diarrhoea—Etoposide—uterine cancer	0.000348	0.00048	CcSEcCtD
Duloxetine—Eye disorder—Doxorubicin—uterine cancer	0.000347	0.000479	CcSEcCtD
Duloxetine—Tinnitus—Doxorubicin—uterine cancer	0.000346	0.000478	CcSEcCtD
Duloxetine—Flushing—Doxorubicin—uterine cancer	0.000344	0.000476	CcSEcCtD
Duloxetine—Cardiac disorder—Doxorubicin—uterine cancer	0.000344	0.000476	CcSEcCtD
Duloxetine—Flatulence—Epirubicin—uterine cancer	0.000344	0.000475	CcSEcCtD
Duloxetine—Tension—Epirubicin—uterine cancer	0.000343	0.000473	CcSEcCtD
Duloxetine—Dysgeusia—Epirubicin—uterine cancer	0.000342	0.000472	CcSEcCtD
Duloxetine—Nervousness—Epirubicin—uterine cancer	0.000339	0.000468	CcSEcCtD
Duloxetine—Back pain—Epirubicin—uterine cancer	0.000338	0.000466	CcSEcCtD
Duloxetine—Angiopathy—Doxorubicin—uterine cancer	0.000337	0.000465	CcSEcCtD
Duloxetine—Dizziness—Etoposide—uterine cancer	0.000336	0.000464	CcSEcCtD
Duloxetine—Muscle spasms—Epirubicin—uterine cancer	0.000336	0.000464	CcSEcCtD
Duloxetine—Immune system disorder—Doxorubicin—uterine cancer	0.000335	0.000463	CcSEcCtD
Duloxetine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000335	0.000462	CcSEcCtD
Duloxetine—Chills—Doxorubicin—uterine cancer	0.000333	0.00046	CcSEcCtD
Duloxetine—Arrhythmia—Doxorubicin—uterine cancer	0.000332	0.000458	CcSEcCtD
Duloxetine—Vision blurred—Epirubicin—uterine cancer	0.000329	0.000454	CcSEcCtD
Duloxetine—Alopecia—Doxorubicin—uterine cancer	0.000328	0.000453	CcSEcCtD
Duloxetine—Mental disorder—Doxorubicin—uterine cancer	0.000325	0.000449	CcSEcCtD
Duloxetine—Ill-defined disorder—Epirubicin—uterine cancer	0.000324	0.000447	CcSEcCtD
Duloxetine—Vomiting—Etoposide—uterine cancer	0.000323	0.000446	CcSEcCtD
Duloxetine—Erythema—Doxorubicin—uterine cancer	0.000323	0.000446	CcSEcCtD
Duloxetine—Malnutrition—Doxorubicin—uterine cancer	0.000323	0.000446	CcSEcCtD
Duloxetine—Anaemia—Epirubicin—uterine cancer	0.000323	0.000446	CcSEcCtD
Duloxetine—Agitation—Epirubicin—uterine cancer	0.000321	0.000443	CcSEcCtD
Duloxetine—Rash—Etoposide—uterine cancer	0.000321	0.000443	CcSEcCtD
Duloxetine—Dermatitis—Etoposide—uterine cancer	0.00032	0.000442	CcSEcCtD
Duloxetine—Headache—Etoposide—uterine cancer	0.000319	0.00044	CcSEcCtD
Duloxetine—Flatulence—Doxorubicin—uterine cancer	0.000318	0.00044	CcSEcCtD
Duloxetine—Tension—Doxorubicin—uterine cancer	0.000317	0.000438	CcSEcCtD
Duloxetine—Dysgeusia—Doxorubicin—uterine cancer	0.000316	0.000437	CcSEcCtD
Duloxetine—Malaise—Epirubicin—uterine cancer	0.000315	0.000435	CcSEcCtD
Duloxetine—Nervousness—Doxorubicin—uterine cancer	0.000314	0.000433	CcSEcCtD
Duloxetine—Vertigo—Epirubicin—uterine cancer	0.000314	0.000433	CcSEcCtD
Duloxetine—Syncope—Epirubicin—uterine cancer	0.000313	0.000432	CcSEcCtD
Duloxetine—Leukopenia—Epirubicin—uterine cancer	0.000313	0.000432	CcSEcCtD
Duloxetine—Back pain—Doxorubicin—uterine cancer	0.000313	0.000432	CcSEcCtD
Duloxetine—Muscle spasms—Doxorubicin—uterine cancer	0.000311	0.000429	CcSEcCtD
Duloxetine—Palpitations—Epirubicin—uterine cancer	0.000309	0.000426	CcSEcCtD
Duloxetine—Loss of consciousness—Epirubicin—uterine cancer	0.000307	0.000424	CcSEcCtD
Duloxetine—Cough—Epirubicin—uterine cancer	0.000305	0.000421	CcSEcCtD
Duloxetine—Vision blurred—Doxorubicin—uterine cancer	0.000305	0.000421	CcSEcCtD
Duloxetine—Convulsion—Epirubicin—uterine cancer	0.000303	0.000418	CcSEcCtD
Duloxetine—Nausea—Etoposide—uterine cancer	0.000302	0.000417	CcSEcCtD
Duloxetine—Hypertension—Epirubicin—uterine cancer	0.000301	0.000416	CcSEcCtD
Duloxetine—Ill-defined disorder—Doxorubicin—uterine cancer	0.0003	0.000414	CcSEcCtD
Duloxetine—Anaemia—Doxorubicin—uterine cancer	0.000299	0.000412	CcSEcCtD
Duloxetine—Myalgia—Epirubicin—uterine cancer	0.000297	0.000411	CcSEcCtD
Duloxetine—Arthralgia—Epirubicin—uterine cancer	0.000297	0.000411	CcSEcCtD
Duloxetine—Chest pain—Epirubicin—uterine cancer	0.000297	0.000411	CcSEcCtD
Duloxetine—Agitation—Doxorubicin—uterine cancer	0.000297	0.00041	CcSEcCtD
Duloxetine—Anxiety—Epirubicin—uterine cancer	0.000296	0.000409	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000295	0.000408	CcSEcCtD
Duloxetine—Discomfort—Epirubicin—uterine cancer	0.000294	0.000406	CcSEcCtD
Duloxetine—Malaise—Doxorubicin—uterine cancer	0.000291	0.000402	CcSEcCtD
Duloxetine—Dry mouth—Epirubicin—uterine cancer	0.000291	0.000402	CcSEcCtD
Duloxetine—Vertigo—Doxorubicin—uterine cancer	0.00029	0.000401	CcSEcCtD
Duloxetine—Syncope—Doxorubicin—uterine cancer	0.00029	0.0004	CcSEcCtD
Duloxetine—Leukopenia—Doxorubicin—uterine cancer	0.000289	0.000399	CcSEcCtD
Duloxetine—Confusional state—Epirubicin—uterine cancer	0.000287	0.000397	CcSEcCtD
Duloxetine—Palpitations—Doxorubicin—uterine cancer	0.000286	0.000394	CcSEcCtD
Duloxetine—Oedema—Epirubicin—uterine cancer	0.000285	0.000394	CcSEcCtD
Duloxetine—Anaphylactic shock—Epirubicin—uterine cancer	0.000285	0.000394	CcSEcCtD
Duloxetine—Loss of consciousness—Doxorubicin—uterine cancer	0.000284	0.000392	CcSEcCtD
Duloxetine—Infection—Epirubicin—uterine cancer	0.000283	0.000391	CcSEcCtD
Duloxetine—Cough—Doxorubicin—uterine cancer	0.000282	0.000389	CcSEcCtD
Duloxetine—Shock—Epirubicin—uterine cancer	0.00028	0.000387	CcSEcCtD
Duloxetine—Convulsion—Doxorubicin—uterine cancer	0.00028	0.000387	CcSEcCtD
Duloxetine—Nervous system disorder—Epirubicin—uterine cancer	0.000279	0.000386	CcSEcCtD
Duloxetine—Thrombocytopenia—Epirubicin—uterine cancer	0.000279	0.000385	CcSEcCtD
Duloxetine—Hypertension—Doxorubicin—uterine cancer	0.000279	0.000385	CcSEcCtD
Duloxetine—Tachycardia—Epirubicin—uterine cancer	0.000278	0.000384	CcSEcCtD
Duloxetine—Skin disorder—Epirubicin—uterine cancer	0.000277	0.000382	CcSEcCtD
Duloxetine—Hyperhidrosis—Epirubicin—uterine cancer	0.000276	0.00038	CcSEcCtD
Duloxetine—Chest pain—Doxorubicin—uterine cancer	0.000275	0.00038	CcSEcCtD
Duloxetine—Arthralgia—Doxorubicin—uterine cancer	0.000275	0.00038	CcSEcCtD
Duloxetine—Myalgia—Doxorubicin—uterine cancer	0.000275	0.00038	CcSEcCtD
Duloxetine—Anxiety—Doxorubicin—uterine cancer	0.000274	0.000379	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000273	0.000377	CcSEcCtD
Duloxetine—Discomfort—Doxorubicin—uterine cancer	0.000272	0.000375	CcSEcCtD
Duloxetine—Anorexia—Epirubicin—uterine cancer	0.000272	0.000375	CcSEcCtD
Duloxetine—Dry mouth—Doxorubicin—uterine cancer	0.000269	0.000372	CcSEcCtD
Duloxetine—Confusional state—Doxorubicin—uterine cancer	0.000266	0.000367	CcSEcCtD
Duloxetine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000264	0.000364	CcSEcCtD
Duloxetine—Oedema—Doxorubicin—uterine cancer	0.000264	0.000364	CcSEcCtD
Duloxetine—Infection—Doxorubicin—uterine cancer	0.000262	0.000362	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00026	0.000359	CcSEcCtD
Duloxetine—Shock—Doxorubicin—uterine cancer	0.000259	0.000358	CcSEcCtD
Duloxetine—Nervous system disorder—Doxorubicin—uterine cancer	0.000259	0.000357	CcSEcCtD
Duloxetine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000258	0.000357	CcSEcCtD
Duloxetine—Insomnia—Epirubicin—uterine cancer	0.000258	0.000356	CcSEcCtD
Duloxetine—Tachycardia—Doxorubicin—uterine cancer	0.000257	0.000355	CcSEcCtD
Duloxetine—Skin disorder—Doxorubicin—uterine cancer	0.000256	0.000354	CcSEcCtD
Duloxetine—Paraesthesia—Epirubicin—uterine cancer	0.000256	0.000353	CcSEcCtD
Duloxetine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000255	0.000352	CcSEcCtD
Duloxetine—Somnolence—Epirubicin—uterine cancer	0.000253	0.00035	CcSEcCtD
Duloxetine—Anorexia—Doxorubicin—uterine cancer	0.000251	0.000347	CcSEcCtD
Duloxetine—Dyspepsia—Epirubicin—uterine cancer	0.000251	0.000346	CcSEcCtD
Duloxetine—Decreased appetite—Epirubicin—uterine cancer	0.000248	0.000342	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000246	0.00034	CcSEcCtD
Duloxetine—Fatigue—Epirubicin—uterine cancer	0.000246	0.000339	CcSEcCtD
Duloxetine—Pain—Epirubicin—uterine cancer	0.000244	0.000337	CcSEcCtD
Duloxetine—Constipation—Epirubicin—uterine cancer	0.000244	0.000337	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00024	0.000332	CcSEcCtD
Duloxetine—Insomnia—Doxorubicin—uterine cancer	0.000239	0.000329	CcSEcCtD
Duloxetine—Paraesthesia—Doxorubicin—uterine cancer	0.000237	0.000327	CcSEcCtD
Duloxetine—Feeling abnormal—Epirubicin—uterine cancer	0.000235	0.000324	CcSEcCtD
Duloxetine—Somnolence—Doxorubicin—uterine cancer	0.000234	0.000324	CcSEcCtD
Duloxetine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000233	0.000322	CcSEcCtD
Duloxetine—Dyspepsia—Doxorubicin—uterine cancer	0.000232	0.000321	CcSEcCtD
Duloxetine—Decreased appetite—Doxorubicin—uterine cancer	0.000229	0.000317	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000228	0.000314	CcSEcCtD
Duloxetine—Fatigue—Doxorubicin—uterine cancer	0.000227	0.000314	CcSEcCtD
Duloxetine—Urticaria—Epirubicin—uterine cancer	0.000226	0.000313	CcSEcCtD
Duloxetine—Pain—Doxorubicin—uterine cancer	0.000225	0.000311	CcSEcCtD
Duloxetine—Constipation—Doxorubicin—uterine cancer	0.000225	0.000311	CcSEcCtD
Duloxetine—Abdominal pain—Epirubicin—uterine cancer	0.000225	0.000311	CcSEcCtD
Duloxetine—Body temperature increased—Epirubicin—uterine cancer	0.000225	0.000311	CcSEcCtD
Duloxetine—Feeling abnormal—Doxorubicin—uterine cancer	0.000217	0.0003	CcSEcCtD
Duloxetine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000216	0.000298	CcSEcCtD
Duloxetine—Hypersensitivity—Epirubicin—uterine cancer	0.00021	0.00029	CcSEcCtD
Duloxetine—Urticaria—Doxorubicin—uterine cancer	0.000209	0.000289	CcSEcCtD
Duloxetine—Abdominal pain—Doxorubicin—uterine cancer	0.000208	0.000288	CcSEcCtD
Duloxetine—Body temperature increased—Doxorubicin—uterine cancer	0.000208	0.000288	CcSEcCtD
Duloxetine—Asthenia—Epirubicin—uterine cancer	0.000204	0.000282	CcSEcCtD
Duloxetine—Pruritus—Epirubicin—uterine cancer	0.000202	0.000278	CcSEcCtD
Duloxetine—Diarrhoea—Epirubicin—uterine cancer	0.000195	0.000269	CcSEcCtD
Duloxetine—Hypersensitivity—Doxorubicin—uterine cancer	0.000194	0.000268	CcSEcCtD
Duloxetine—Asthenia—Doxorubicin—uterine cancer	0.000189	0.000261	CcSEcCtD
Duloxetine—Dizziness—Epirubicin—uterine cancer	0.000188	0.00026	CcSEcCtD
Duloxetine—Pruritus—Doxorubicin—uterine cancer	0.000187	0.000258	CcSEcCtD
Duloxetine—Vomiting—Epirubicin—uterine cancer	0.000181	0.00025	CcSEcCtD
Duloxetine—Diarrhoea—Doxorubicin—uterine cancer	0.00018	0.000249	CcSEcCtD
Duloxetine—Rash—Epirubicin—uterine cancer	0.00018	0.000248	CcSEcCtD
Duloxetine—Dermatitis—Epirubicin—uterine cancer	0.00018	0.000248	CcSEcCtD
Duloxetine—Headache—Epirubicin—uterine cancer	0.000179	0.000247	CcSEcCtD
Duloxetine—Dizziness—Doxorubicin—uterine cancer	0.000174	0.000241	CcSEcCtD
Duloxetine—Nausea—Epirubicin—uterine cancer	0.000169	0.000234	CcSEcCtD
Duloxetine—Vomiting—Doxorubicin—uterine cancer	0.000168	0.000232	CcSEcCtD
Duloxetine—Rash—Doxorubicin—uterine cancer	0.000166	0.00023	CcSEcCtD
Duloxetine—Dermatitis—Doxorubicin—uterine cancer	0.000166	0.000229	CcSEcCtD
Duloxetine—Headache—Doxorubicin—uterine cancer	0.000165	0.000228	CcSEcCtD
Duloxetine—Nausea—Doxorubicin—uterine cancer	0.000157	0.000216	CcSEcCtD
